Plrx

Plrx (PF3D7_0303600, plasmoredoxin) is a 22 kDa thiol-disulfide oxidoreductase unique to malarial parasites that operates within the parasite's cytosolic redox network in blood-stage forms (PMID:12631266). As a thioredoxin-superfamily member bearing a conserved CxxC active-site motif, reduced Plrx displays classical oxidoreductase activity in the insulin-reduction assay and is regenerated by glutathione and, more efficiently, by the dithiol redox proteins thioredoxin, glutaredoxin, trypanothione, and tryparedoxin (PMID:12631266). Functionally it serves as an electron donor for ribonucleotide reductase (PMID:12631266) and for the 2-Cys peroxiredoxin TPx1, placing it upstream in the antioxidant cascade (PMID:16307478), and it catalyzes protein deglutathionylation while itself being a substrate of S-glutathionylation (PMID:21595565). Active-site mutant trapping and SPR define a target set of at least 21 proteins spanning protein biosynthesis, energy metabolism, signal transduction, and SAM metabolism, with direct binding confirmed for ornithine aminotransferase and S-adenosyl-L-homocysteine hydrolase (PMID:19360125). A 1.6 Å crystal structure reveals a modified thioredoxin fold with a distinct C-terminal domain and a CxxC motif lacking the usual proline; Plrx is catalytically active as a monomer and inactive as a redox-sensitive dimer (PMID:35434650). Despite these biochemical roles, Plrx is dispensable for life cycle progression in the P. berghei rodent model (PMID:18575607).

1. 2003 High

   Establishing whether malarial parasites possess a distinct redox-active enzyme answered what molecular activity Plrx contributes: it defined Plrx as a parasite-specific thioredoxin-family oxidoreductase reducible by both glutathione and dithiols and capable of donating electrons to ribonucleotide reductase.

   Evidence recombinant expression, insulin-reduction and kinetic assays, phylogenetic analysis in P. falciparum

   PMID:12631266

   Open questions at the time

   • Physiological reductant in vivo not resolved among the several capable dithiols
   • No cellular localization or expression dynamics across stages beyond blood-stage presence
2. 2005 High

   Identifying an electron acceptor placed Plrx within a defined antioxidant pathway rather than as an isolated redox protein: it acts upstream of the 2-Cys peroxiredoxin TPx1.

   Evidence in vitro reconstitution with recombinant proteins plus TPx1 cysteine mutagenesis and stopped-flow kinetics in P. falciparum

   PMID:16307478

   Open questions at the time

   • Relative contribution of Plrx versus thioredoxin as the physiological TPx1 reductant not quantified
   • In vivo relevance of the Plrx-TPx1 branch untested
3. 2008 Medium

   Testing genetic requirement addressed whether Plrx's biochemical activities are essential: gene disruption showed it is dispensable for the complete parasite life cycle.

   Evidence targeted gene knockout and life cycle phenotyping in P. berghei

   PMID:18575607

   Open questions at the time

   • Rodent model only; P. falciparum requirement untested
   • Possible functional redundancy with other thioredoxin-family reductases not assessed
4. 2009 Medium

   Defining a target repertoire answered which cellular processes Plrx acts on: active-site trapping and SPR identified ~21 candidate partners with confirmed binding to OAT and SAH hydrolase, implicating Plrx in biosynthesis, metabolism, and SAM pathways.

   Evidence active-site Cys mutant affinity trapping with mass spectrometry and BIAcore SPR in P. falciparum

   PMID:19360125

   Open questions at the time

   • Individual interactions beyond OAT and SAH hydrolase not independently validated
   • Functional consequence of these interactions (e.g., redox regulation of the targets) not demonstrated
5. 2010 Low

   Cross-referencing the OAT interaction probed whether Plrx regulates a specific metabolic enzyme, but OAT activation was demonstrated only for thioredoxin, leaving Plrx's regulatory role at the interaction level.

   Evidence OAT crystal structure and cysteine mutagenesis with cross-referenced SPR data in P. falciparum

   PMID:20673832

   Open questions at the time

   • No activation kinetics reported for Plrx itself, only for thioredoxin
   • Whether Plrx modulates OAT activity remains undemonstrated
6. 2011 Medium

   Characterizing glutathionylation biology clarified a distinct catalytic activity: Plrx catalyzes protein deglutathionylation and is itself a glutathionylation target, linking it to reversible redox modification of the parasite proteome.

   Evidence enzymatic deglutathionylation assay plus glutathionylome proteomics in P. falciparum

   PMID:21595565

   Open questions at the time

   • Physiological deglutathionylation substrates not identified
   • Relative efficiency versus glutaredoxin 1 and thioredoxin 1 in cells not established
7. 2022 High

   Solving the atomic structure connected activity to oligomeric state: Plrx adopts a modified thioredoxin fold with an atypical CxxC motif and is active as a monomer but inactive as a redox-dependent dimer.

   Evidence 1.6 Å X-ray crystallography and monomer/dimer structural analysis in P. falciparum

   PMID:35434650

   Open questions at the time

   • Proposed membrane/plasminogen binding via the lysine-rich dimer interface is structurally inferred, not functionally tested
   • Regulation of the monomer-dimer switch in vivo unknown

• Whether Plrx's biochemically defined redox activities and target interactions translate into a specific cellular or pathological role in human malaria remains unresolved.
• No P. falciparum loss-of-function phenotype
• Functional significance of the ~21-member target set uncharacterized
• In vivo redox partner and physiological electron flow undefined